www.aspenpharma.com
Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion | Aspen Pharmacare
Aspen Holdings, through its wholly owned subsidiary Aspen Global Incorporated, has entered into binding agreements for the 100% sale of Aspen Asia Pacific (excluding China) for R26.5 billion.
Leggi l'articolo su www.aspenpharma.com